We are live on
!
Find out more
VCNX
Vaccinex, Inc. Common Stock
VCNX
VCNX
Delisted
VCNX was delisted on the 17th of December, 2024.
18 hedge funds and large institutions have $2.92M invested in Vaccinex, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
193% more capital invested
Capital invested by funds: $995K → $2.92M (+$1.92M)
18% less funds holding
Funds holding: 22 → 18 (-4)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
5
Closed
9
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$1K
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.63M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$2.57M |
| 3 |
AC
Armistice Capital
New York
|
+$2.47M |
| 4 |
Millennium Management
New York
|
+$49.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$45.8K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$36.7K |
| 2 |
State Street
Boston,
Massachusetts
|
-$25.4K |
| 3 |
Renaissance Technologies
New York
|
-$16K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8.32K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.69K |
